Nora Möhn

1.2k total citations
49 papers, 699 citations indexed

About

Nora Möhn is a scholar working on Oncology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Nora Möhn has authored 49 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 12 papers in Neurology. Recurrent topics in Nora Möhn's work include Multiple Sclerosis Research Studies (17 papers), Polyomavirus and related diseases (10 papers) and Full-Duplex Wireless Communications (7 papers). Nora Möhn is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Polyomavirus and related diseases (10 papers) and Full-Duplex Wireless Communications (7 papers). Nora Möhn collaborates with scholars based in Germany, Israel and Slovakia. Nora Möhn's co-authors include Thomas Skripuletz, Martin Stangel, Kurt‐Wolfram Sühs, Gernot Beutel, Ralf Gutzmer, Imke Satzger, Philipp Schwenkenbecher, Philipp Ivanyi, Franz Felix Konen and Stefan Gingele and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Nora Möhn

42 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nora Möhn Germany	16	306	224	185	133	127	49	699
Emiko Takahashi Japan	16	410 1.3×	424 1.9×	166 0.9×	101 0.8×	159 1.3×	74	958
Anna P. Koo United States	15	238 0.8×	179 0.8×	162 0.9×	43 0.3×	272 2.1×	38	935
Jocelyn R. Farmer United States	14	144 0.5×	98 0.4×	75 0.4×	188 1.4×	457 3.6×	50	939
Sarah Nagle United States	10	296 1.0×	205 0.9×	90 0.5×	68 0.5×	93 0.7×	29	503
Rafael Andreu Spain	12	164 0.5×	202 0.9×	44 0.2×	51 0.4×	71 0.6×	26	593
Stefan Gattenloehner Germany	14	243 0.8×	204 0.9×	64 0.3×	286 2.2×	262 2.1×	31	937
John M. McGregor United States	11	102 0.3×	234 1.0×	59 0.3×	88 0.7×	44 0.3×	25	596
T Kirchner Germany	17	136 0.4×	108 0.5×	387 2.1×	99 0.7×	137 1.1×	42	863
P. Gjörstrup Sweden	10	187 0.6×	259 1.2×	123 0.7×	45 0.3×	293 2.3×	15	912
Bengü Nisa Akay Türkiye	17	305 1.0×	172 0.8×	41 0.2×	36 0.3×	137 1.1×	120	937

Countries citing papers authored by Nora Möhn

Since Specialization

Citations

This map shows the geographic impact of Nora Möhn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Möhn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Möhn more than expected).

Fields of papers citing papers by Nora Möhn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Möhn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Möhn. The network helps show where Nora Möhn may publish in the future.

Co-authorship network of co-authors of Nora Möhn

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Möhn. A scholar is included among the top collaborators of Nora Möhn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Möhn. Nora Möhn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konen, Franz Felix, Torsten Witte, Diana Ernst, et al.. (2025). Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis. Neurological Research and Practice. 7(1). 48–48.

Konen, Franz Felix, Stefan Gingele, Martin W. Hümmert, et al.. (2024). Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset. Multiple Sclerosis and Related Disorders. 91. 105886–105886. 1 indexed citations

Möhn, Nora, Sandra Nay, Philipp Schwenkenbecher, et al.. (2024). Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas. Journal of Neurology. 271(10). 6970–6982. 1 indexed citations

Nay, Sandra, Nora Möhn, Lea Grote‐Levi, et al.. (2024). Combined treatment with allogeneic Epstein–Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report. Therapeutic Advances in Neurological Disorders. 17. 4233535005–4233535005.

Odak, Ivan, Lennart Riemann, J. Schneider, et al.. (2024). Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time. Frontiers in Immunology. 15. 1298598–1298598. 2 indexed citations

Möhn, Nora, Lea Grote‐Levi, Tabea Seeliger, et al.. (2023). Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity. Cancer Medicine. 12(8). 9373–9383. 18 indexed citations

Grote‐Levi, Lea, Nora Möhn, Agnes Bonifacius, et al.. (2023). Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy. Neurology Neuroimmunology & Neuroinflammation. 10(5). 1 indexed citations

Möhn, Nora, Lea Grote‐Levi, Franziska Hopfner, et al.. (2022). Innovative therapeutic concepts of progressive multifocal leukoencephalopathy. Journal of Neurology. 269(5). 2403–2413. 8 indexed citations

Konen, Franz Felix, Peter Lange, Ulrich Wurster, et al.. (2022). The Influence of the Ventricular-Lumbar Gradient on Cerebrospinal Fluid Analysis in Serial Samples. Brain Sciences. 12(3). 410–410. 6 indexed citations

10.

Konen, Franz Felix, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.. (2022). Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications. Cells. 11(14). 2165–2165. 5 indexed citations

11.

Möhn, Nora, Lea Grote‐Levi, Victoria Panagiota, et al.. (2022). Neurological management and work-up of neurotoxicity associated with CAR T cell therapy. SHILAP Revista de lepidopterología. 4(1). 1–1. 18 indexed citations

12.

Müschen, Lars Hendrik, Alma Osmanovic, Konstantin Fritz Jendretzky, et al.. (2021). Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients. Brain Sciences. 11(3). 296–296. 16 indexed citations

13.

Möhn, Nora, Mike P. Wattjes, Ortwin Adams, et al.. (2021). PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy. Therapeutic Advances in Neurological Disorders. 14. 1280215252–1280215252. 12 indexed citations

14.

Möhn, Nora, et al.. (2021). The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules. 11(9). 1372–1372. 3 indexed citations

15.

Schwenkenbecher, Philipp, Thomas Skripuletz, Peter Lange, et al.. (2021). Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 8(6). 20 indexed citations

16.

Möhn, Nora, Kurt‐Wolfram Sühs, Martin Stangel, et al.. (2021). Checkpoint inhibitor–induced autoimmune central nervous system disorder in patients with metastatic melanoma and Hodgkin’s lymphoma. Clinical and Experimental Neuroimmunology. 12(2). 127–134. 1 indexed citations

17.

Möhn, Nora, Ralf Gutzmer, Imke Satzger, et al.. (2020). Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. Journal of Oncology. 2020. 1–9. 7 indexed citations

18.

Möhn, Nora, Elena Bruni, Arne Schröder, et al.. (2020). Synthetic retinoid AM80 inhibits IL‐17 production of gamma delta T cells and ameliorates biliary atresia in mice. Liver International. 40(12). 3031–3041. 5 indexed citations

19.

Möhn, Nora, Franz Felix Konen, Refik Pul, et al.. (2020). Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine. 9(12). 4067–4067. 46 indexed citations

20.

Gingele, Stefan, Franz Felix Konen, Martin W. Hümmert, et al.. (2018). Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients. Cells. 8(1). 12–12. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact